Department of Dermatology, Hospital Sultanah Aminah Johor Bahru, Johor, Malaysia.
Clinical School Johor Bahru, Jeffrey Cheah School of Medicine & Health Sciences, Monash University, Johor, Malaysia.
Br J Dermatol. 2022 Nov;187(5):713-721. doi: 10.1111/bjd.21768. Epub 2022 Aug 8.
There are no population-based epidemiological data on psoriasis in Southeast Asia, including Malaysia.
To determine the incidence and prevalence of psoriasis over 11 years in multiethnic Johor Bahru, Malaysia.
A population-based cohort study was made using the Teleprimary Care database between January 2010 and December 2020. Cases of psoriasis, identified by ICD-10 diagnostic codes, were validated by dermatologists. Annual prevalence and incidence were estimated and stratified by age, sex and ethnicity.
We identified 3932 people with dermatologist-confirmed psoriasis, including 1830 incident cases, among 1 164 724 Malaysians, yielding an 11-year prevalence of 0·34% [95% confidence interval (CI) 0·33-0·35] and incidence of 34·2 per 100 000 person-years (95% CI 32·6-35·8). Rates were higher in Indian patients; the prevalences were 0·54% (0·50-0·58) in Indian, 0·38% (0·36-0·40) in Chinese and 0·29% (0·28-0·30) in Malay patients, and the respective incidences per 100 000 person-years were 52·5 (47·3-57·7), 38·0 (34·1-41·8) and 30·0 (28·2-31·8). Rates were higher in males; the prevalence was 0·39% (0·37-0·41) in males and 0·29% (0·27-0·30) in females, and the respective incidences per 100 000 person-years were 40·7 (38·2-43·2) and 28·3 (26·4-30·3). Between 2010 and 2020, annual psoriasis prevalence and incidence increased steadily from 0·27% to 0·51% and from 27·8 to 60·9 per 100 000 person-years, respectively. Annual rates were consistently higher in male and Indian patients. Overall, psoriasis was significantly more common in males than females [odds ratio (OR) 1·37, 95% CI 1·29-1·46] and in Indian and Chinese patients vs. Malay (OR 1·85, 1·71-2·01 and OR 1·30, 1·20-1·41, respectively). Prevalence increased with age, with the highest rates in the groups aged 50-59 and 60-69 years at 0·67% and 0·66%, respectively. A modest bimodal trend in age of psoriasis onset was observed, with first and second peaks at 20-29 and 50-59 years. Disease onset was significantly earlier in females than males [mean (SD) 36·8 (17·3) vs. 42·0 (17·2) years, P < 0·001] and in Malay vs. Indian and Chinese patients [mean (SD): Malay 36·4 (17·5), Indian 40·8 (15·2), Chinese 47·4 (16·9) years, P < 0·001].
We found that psoriasis incidence and prevalence are increasing and varied by age, sex and ethnicity. Our findings should help inform healthcare planning and management for patients with psoriasis in Malaysia. What is already known about this topic? The incidence and prevalence of psoriasis are generally lower in Asian populations and children. There is a lack of agreement on sex-specific differences in psoriasis incidence and prevalence. There has been no population-based study on the incidence and prevalence of psoriasis in Southeast Asia, including Malaysia. There is no information on differences in psoriasis prevalence and incidence by sex, age and ethnicity in Malaysia. What does this study add? Psoriasis incidence and prevalence are increasing in the multiethnic population of Johor Bahru, Malaysia. Incidence and prevalence rates were higher in male than female patients and were consistently highest among Indian patients, followed by Chinese and Malay. A modest bimodality in the age of psoriasis onset was observed among the groups aged 20-29 and 50-59 years. Psoriasis onset was significantly later in male than female patients and in Chinese vs. Indian and Malay patients.
东南亚(包括马来西亚)缺乏基于人群的银屑病流行病学数据。
确定马来西亚柔佛州多民族 11 年间银屑病的发病率和患病率。
利用 2010 年 1 月至 2020 年 12 月间的远程初级保健数据库,进行了一项基于人群的队列研究。通过皮肤科医生确认了银屑病病例,并用 ICD-10 诊断代码进行了验证。估计了每年的患病率和发病率,并按年龄、性别和种族进行分层。
我们在 1164724 名马来西亚人中发现了 3932 名经皮肤科医生确诊的银屑病患者,包括 1830 例新发病例,11 年的患病率为 0.34%(95%置信区间 0.33-0.35),发病率为 34.2/10 万患者年(95%置信区间 32.6-35.8)。印度患者的发病率更高;印度患者的患病率分别为 0.54%(0.50-0.58)、中国患者为 0.38%(0.36-0.40)、马来患者为 0.29%(0.28-0.30),相应的每 10 万患者年发病率分别为 52.5(47.3-57.7)、38.0(34.1-41.8)和 30.0(28.2-31.8)。男性的发病率更高;男性的患病率为 0.39%(0.37-0.41),女性为 0.29%(0.27-0.30),相应的每 10 万患者年发病率分别为 40.7(38.2-43.2)和 28.3(26.4-30.3)。2010 年至 2020 年间,银屑病的年患病率和发病率从 0.27%稳步上升至 0.51%和从 27.8 上升至 60.9/10 万患者年,分别。男性和印度患者的年发病率始终较高。总体而言,银屑病在男性中比女性更为常见(比值比 1.37,95%置信区间 1.29-1.46),在印度患者和中国患者中比马来患者更为常见(比值比 1.85,1.71-2.01 和 1.30,1.20-1.41)。患病率随年龄增长而增加,50-59 岁和 60-69 岁的人群患病率最高,分别为 0.67%和 0.66%。银屑病发病年龄呈适度双峰趋势,第一和第二高峰分别为 20-29 岁和 50-59 岁。女性银屑病发病年龄明显早于男性(平均[标准差]36.8[17.3]岁 vs. 42.0[17.2]岁,P<0.001),马来患者发病年龄明显早于印度患者和中国患者(平均[标准差]:马来 36.4[17.5]岁,印度 40.8[15.2]岁,中国 47.4[16.9]岁,P<0.001)。
我们发现银屑病的发病率和患病率正在上升,且与年龄、性别和种族有关。我们的研究结果应有助于为马来西亚的银屑病患者提供医疗保健规划和管理方面的信息。关于这个主题,已经知道些什么?银屑病在亚洲人群和儿童中的发病率和患病率普遍较低。关于银屑病发病率和患病率的性别差异,目前尚无共识。在包括马来西亚在内的东南亚地区,还没有基于人群的银屑病发病率和患病率研究。马来西亚没有关于银屑病患病率和发病率的性别、年龄和种族差异的信息。这项研究增加了哪些新的知识?柔佛州马来西亚多民族人群中银屑病的发病率和患病率正在上升。发病率和患病率在男性患者中高于女性患者,且在印度患者中始终最高,其次是中国患者和马来患者。20-29 岁和 50-59 岁的患者中,银屑病发病年龄呈适度双峰趋势。银屑病发病年龄在女性患者中明显晚于男性患者,在汉族患者中明显晚于印度患者和马来患者。